160 related articles for article (PubMed ID: 20951583)
1. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.
Wheatley NC; Andrews KT; Tran TL; Lucke AJ; Reid RC; Fairlie DP
Bioorg Med Chem Lett; 2010 Dec; 20(23):7080-4. PubMed ID: 20951583
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy.
Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA
Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
[TBL] [Abstract][Full Text] [Related]
6. Potent antimalarial activity of histone deacetylase inhibitor analogues.
Andrews KT; Tran TN; Lucke AJ; Kahnberg P; Le GT; Boyle GM; Gardiner DL; Skinner-Adams TS; Fairlie DP
Antimicrob Agents Chemother; 2008 Apr; 52(4):1454-61. PubMed ID: 18212103
[TBL] [Abstract][Full Text] [Related]
7. Identification of new antimalarial leads by use of virtual screening against cytochrome bc₁.
Rodrigues T; Moreira R; Gut J; Rosenthal PJ; O Neill PM; Biagini GA; Lopes F; dos Santos DJ; Guedes RC
Bioorg Med Chem; 2011 Nov; 19(21):6302-8. PubMed ID: 21958736
[TBL] [Abstract][Full Text] [Related]
8. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid as a potential inhibitor of Plasmodium falciparum histone deacetylase 1 (PfHDAC1): an in silico approach.
Elbadawi MA; Awadalla MK; Hamid MM; Mohamed MA; Awad TA
Int J Mol Sci; 2015 Feb; 16(2):3915-31. PubMed ID: 25679451
[TBL] [Abstract][Full Text] [Related]
10. Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite.
Giannini G; Battistuzzi G; Vignola D
Bioorg Med Chem Lett; 2015 Feb; 25(3):459-61. PubMed ID: 25563890
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase.
Sriwilaijaroen N; Boonma S; Attasart P; Pothikasikorn J; Panyim S; Noonpakdee W
Biochem Biophys Res Commun; 2009 Apr; 381(2):144-7. PubMed ID: 19338767
[TBL] [Abstract][Full Text] [Related]
12. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites.
Engel JA; Jones AJ; Avery VM; Sumanadasa SD; Ng SS; Fairlie DP; Skinner-Adams T; Andrews KT
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):117-26. PubMed ID: 26199860
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial activity of N(6)-substituted adenosine derivatives. Part 3.
Herforth C; Wiesner J; Heidler P; Sanderbrand S; Van Calenbergh S; Jomaa H; Link A
Bioorg Med Chem; 2004 Feb; 12(4):755-62. PubMed ID: 14759735
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
[TBL] [Abstract][Full Text] [Related]
15. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2.
Cunico W; Gomes CR; Facchinetti V; Moreth M; Penido C; Henriques MG; Varotti FP; Krettli LG; Krettli AU; da Silva FS; Caffarena ER; de Magalhães CS
Eur J Med Chem; 2009 Sep; 44(9):3816-20. PubMed ID: 19403210
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase.
de Beer TA; Louw AI; Joubert F
Bioorg Med Chem; 2006 Jul; 14(13):4433-43. PubMed ID: 16517168
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Plasmodium falciparum pH regulation by small molecule indole derivatives results in rapid parasite death.
van Schalkwyk DA; Chan XW; Misiano P; Gagliardi S; Farina C; Saliba KJ
Biochem Pharmacol; 2010 May; 79(9):1291-9. PubMed ID: 20067768
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth.
Prusty D; Mehra P; Srivastava S; Shivange AV; Gupta A; Roy N; Dhar SK
FEMS Microbiol Lett; 2008 May; 282(2):266-72. PubMed ID: 18397290
[TBL] [Abstract][Full Text] [Related]
20. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]